The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: Pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention

Medical Clinics of North America

Volumn 89, Issue 2, 2005, Pages 313-344

  Marshall, Barry J ^a,b   Windsor, Helen M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; BISMUTH CITRATE; BISMUTH SALICYLATE; CAGA PROTEIN; CLARITHROMYCIN; FURAZOLIDONE; HISTAMINE H2 RECEPTOR ANTAGONIST; LEVOFLOXACIN; METRONIDAZOLE; OMEPRAZOLE; PENICILLIN G; PROTON PUMP INHIBITOR; RABEPRAZOLE; RIFABUTIN; TETRACYCLINE;

ANTIBIOTIC THERAPY; BACTERIAL GENETICS; BACTERIAL TRANSMISSION; BITTER TASTE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; DISEASE ASSOCIATION; DUODENUM ULCER; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; GENE SEQUENCE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTORY OF MEDICINE; HUMAN; MOLECULAR GENETICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; RISK FACTOR; SCREENING; SEROLOGY; STOMACH ADENOCARCINOMA; STOMACH LYMPHOMA; TASTE DISORDER; TAXONOMY;

ADENOCARCINOMA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA; STOMACH NEOPLASMS;

EID: 12344299467     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2004.09.001     Document Type: Review

References (147)

1. J.E. Everhart Recent developments in the epidemiology of Helicobacter pylori Gastroenterol Clin North Am 29 3 2000 559 578
2. J. Parsonnet, G.D. Friedman, and D.P. Vandersteen Helicobacter pylori infection and the risk of gastric carcinoma N Engl J Med 325 1991 1127 1131
3. B. Marshall Commentary: Helicobacter as the environmental factor in Susser and Stein's cohort theory of peptic ulcer disease Int J Epidemiol 31 1 2002 21 22
4. P. Wang, and R. Adair Helicobacter pylori in immigrants from East Africa J Gen Intern Med 14 9 1999 567 568
5. T.K. Chow, J.R. Lambert, and M.L. Wahlqvist Helicobacter pylori in Melbourne Chinese immigrants: evidence for oral-oral transmission via chopsticks J Gastroenterol Hepatol 10 5 1995 562 569
6. H.M. Malaty, and D.Y. Graham Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection Gut 35 6 1994 742 745
7. M. Kekki, T. Ihamaki, and P. Sipponen Heterogeneity in susceptibility to chronic gastritis in relatives of gastric cancer patients with different histology of carcinoma Scand J Gastroenterol 10 7 1975 737 745
8. J.R. Warren, and B. Marshall Unidentified curved bacilli on gastric epithelium in active chronic gastritis [letter] Lancet 1 1983 1273 1275
9. J. Ferlay, F. Bray, and P. Pisani GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. Version 1.0 2001 IARC Press Lyon
10. C.P. Howson, T. Hiyama, and E.L. Wynder The decline in gastric cancer: epidemiology of an unplanned triumph Epidemiol Rev 8 1986 1 27
11. J. Parsonnet, M.J. Blaser, and G.I. Perez Perez Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists Gastroenterology 102 1992 41 46
12. The EUROGAST Study Group An international association between Helicobacter pylori infection and gastric cancer Lancet 341 1993 1359 1362
13. J.Q. Huang, G.F. Zheng, and K. Sumanac Meta-analysis of the relationship between cagA seropositivity and gastric cancer Gastroenterology 125 6 2003 1636 1644
14. S. Hisamichi, P. Fukao, and N. Sugawara Evaluation of mass screening programme for stomach cancer in Japan A.B. Miller J. Chamberlain N.E. Day Cancer screening 1991 Cambridge University Press Cambridge 357 372
15. B.J. Marshall, and J.R. Warren Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1 1984 1311 1315
16. D.J. Cullen, B.J. Collins, and K.J. Christiansen When is Helicobacter pylori infection acquired? Gut 34 12 1993 1681 1682
17. T. Kumagai, H.M. Malaty, and D.Y. Graham Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study J Infect Dis 178 3 1998 717 721
18. F. Megraud, M.P. Brassens Rabbe, and F. Denis Seroepidemiology of Campylobacter pylori infection in various populations J Clin Microbiol 27 1989 1870 1873
19. H.M. Mitchell, Y.Y. Li, and P.J. Hu Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition J Infect Dis 166 1992 149 153
20. P.B. Sullivan, J.E. Thomas, and D.G. Wight Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition Arch Dis Child 65 1990 189 191
21. P.D. Klein, D.Y. Graham, and A. Gaillour Water source as risk factor for Helicobacter pylori infection in Peruvian children Lancet 337 1991 1503 1506
22. A. Fraser, S. Williamson, and M. Lane Nurse-led dyspepsia clinic using the urea breath test for Helicobacter pylori N Z Med J 116 1176 2003 479 487
23. H. Enroth, and L. Engstrand Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens J Clin Microbiol 33 8 1995 2162 2165
24. G. Soto, C.T. Bautista, and D.E. Roth Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy J Infect Dis 188 9 2003 1263 1275
25. M. Woodward, C. Morrison, and K. McColl An investigation into factors associated with Helicobacter pylori infection J Clin Epidemiol 53 2 2000 175 181
26. M.A. Mendall, P.M. Goggin, and N. Molineaux Childhood living conditions and Helicobacter pylori seropositivity in adult life Lancet 339 1992 896 897
27. M. Oona, M. Utt, and I. Nilsson Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes Helicobacter 9 3 2004 233 241
28. S.K. Lin, J.R. Lambert, and L. Nicholson Prevalence of Helicobacter pylori in a representative Anglo-Celtic population of urban Melbourne J Gastroenterol Hepatol 13 5 1998 505 510
29. M.A. Staat, D. Kruszon-Moran, and G.M. McQuillan A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States J Infect Dis 174 5 1996 1120 1123
30. J. Torres, Y. Leal-Herrera, and G. Perez-Perez A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico J Infect Dis 178 4 1998 1089 1094
31. C.G. Harper, Y. Feng, and S. Xu Helicobacter cetorum sp. nov., a urease-positive Helicobacter species isolated from dolphins and whales J Clin Microbiol 40 12 2002 4536 4543
32. D. Falush, C. Kraft, and N.S. Taylor Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age Proc Natl Acad Sci U S A 98 26 2001 15056 15061
33. C. Ghose, G.I. Perez-Perez, and M.G. Dominguez-Bello East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriage Proc Natl Acad Sci U S A 99 23 2002 15107 15111
34. S. Censini, C. Lange, and Z. Xiang Cag, a pathogenicity island of Helicobacter pylori encodes type I-specific and disease-associated virulence factors Proc Natl Acad Sci USA 93 25 1996 14648 14653
35. M. Stein, R. Rappuoli, and A. Covacci Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation Proc Natl Acad Sci U S A 97 3 2000 1263 1268
36. C.S. Goodwin, E.D. Blincow, and J.R. Warren Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa J Clin Pathol 38 1985 1127 1131
37. T.L. Cover The vacuolating cytotoxin of Helicobacter pylori Mol Microbiol 20 2 1996 241 246
38. M.S. McClain, W. Schraw, and V. Ricci Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells Mol Microbiol 37 2 2000 433 442
39. + Helicobacter pylori strains J Clin Microbiol 33 6 1995 1496 1500
40. V.J. Warburton, S. Everett, and N.P. Mapstone Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis J Clin Pathol 51 1 1998 55 61
41. S. Miehlke, K. Kibler, and J.G. Kim Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States Am J Gastroenterol 91 7 1996 1322 1325
42. M. Gerhard, N. Lehn, and N. Neumayer Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin Proc Natl Acad Sci U S A 96 22 1999 12778 12783
43. M. Hatakeyama Helicobacter pylori CagA: a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins Microbes Infect 5 2 2003 143 150
44. J.C. Atherton, P.M. Sharp, and T.L. Cover Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limited recombination Curr Microbiol 39 4 1999 211 218
45. H. Iwamoto, D.M. Czajkowsky, and T.L. Cover VacA from Helicobacter pylori: a hexameric chloride channel FEBS Lett 450 1-2 1999 101 104
46. D. Ilver, S. Barone, and D. Mercati Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism Cell Microbiol 6 2 2004 167 174
47. T.L. Cover, U.S. Krishna, and D.A. Israel Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin Cancer Res 63 5 2003 951 957
48. H. Ashktorab, A. Ahmed, and G. Littleton p53 and p14 increase sensitivity of gastric cells to H pylori-induced apoptosis Dig Dis Sci 48 7 2003 1284 1291
49. M.J. Blaser, and J.C. Atherton Helicobacter pylori persistence: biology and disease J Clin Invest 113 3 2004 321 333
50. B.J. Marshall, J.A. Armstrong, and D.B. McGechie Attempt to fulfil Koch's postulates for pyloric campylobacter Med J Aust 142 1985 436 439
51. D.Y. Graham, A.R. Opekun, and M.S. Osato Challenge model for Helicobacter pylori infection in human volunteers Gut 53 9 2004 1235 1243
52. A. Morris, and G. Nicholson Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH Am J Gastroenterol 82 1987 192 199
53. D.Y. Graham, L.C. Alpert, and J.L. Smith Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria Am J Gastroenterol 83 1988 974 980
54. S. Kawano, M. Murakami, and H. Saita Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication J Gastroenterol 31 Suppl 9 1996 41 43
55. W. Harford, F. Lanza, and A. Arora Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection Helicobacter 1 4 1996 243 250
56. S. Miehlke, G.A. Mannes, and N. Lehn An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively Aliment Pharmacol Ther 11 2 1997 323 329
57. T. Lind, F. Megraud, and P. Unge The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies Gastroenterology 116 1999 248 253
58. F. Bazzoli, M. Zagari, and P. Pozzato Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study Aliment Pharmacol Ther 12 5 1998 439 445
59. W.M. Wong, Q. Gu, and S.K. Lam Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection Aliment Pharmacol Ther 17 4 2003 553 560
60. T.J. Borody, P. Cole, and S. Noonan Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication Med J Aust 151 1989 431 435
61. D.Y. Graham, G.M. Lew, and H.M. Malaty Factors influencing the eradication of Helicobacter pylori with triple therapy Gastroenterology 102 1992 493 496
62. N. Uemura, S. Okamoto, and S. Yamamoto Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 11 2001 784 789
63. K. Yokota, Y. Kurebayashi, and Y. Takayama Colonization of Helicobacter pylori in the gastric mucosa of Mongolian gerbils Microbiol Immunol 35 1991 475 480
64. T. Ikeno, H. Ota, and A. Sugiyama Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils Am J Pathol 154 3 1999 951 960
65. T. Watanabe, M. Tada, and H. Nagai Helicobacter pylori infection induces gastric cancer in mongolian gerbils Gastroenterology 115 3 1998 642 648
66. F. Maruta, H. Ota, and R.M. Genta Role of N-methyl-N-nitrosourea in the induction of intestinal metaplasia and gastric adenocarcinoma in Mongolian gerbils infected with Helicobacter pylori Scand J Gastroenterol 36 3 2001 283 290
67. M. Tokieda, S. Honda, and T. Fujioka Effect of Helicobacter pylori infection on the N-methyl-N-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in mongolian gerbils Carcinogenesis 20 7 1999 1261 1266
68. J.G. Fox, T.C. Wang, and A.B. Rogers Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia Gastroenterology 124 7 2003 1879 1890
69. A. Sugiyama, F. Maruta, and T. Ikeno Helicobacter pylori infection enhances N-methyl-N-nitrosourea- induced stomach carcinogenesis in the Mongolian gerbil Cancer Res 58 10 1998 2067 2069
70. M. Hamada, T. Fujiwara, and A. Hizuta The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers J Cancer Res Clin Oncol 122 6 1996 360 365
71. S.S. Mirvish Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC Cancer Lett 93 1 1995 17 48
72. E. Touati, V. Michel, and J.M. Thiberge Chronic Helicobacter pylori infections induce gastric mutations in mice Gastroenterology 124 5 2003 1408 1419
73. P. Sipponen, and B. Marshall Gastritis and gastric cancer: Western countries Gastroenterol Clin North Am 29 3 2000 579 592
74. J. Mikaeli, R. Malekzadeh, and B. Ziad Alizadeh Prevalence of Helicobacter pylori in two Iranian provinces with high and low incidence of gastric carcinoma Arch Ira Med 3 2000 6 9
75. W.K. Leung, S.R. Lin, and J.Y. Ching Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication Gut 53 9 2004 1244 1249
76. L.E. Hansson, O. Nyren, and A.W. Hsing The risk of stomach cancer in patients with gastric or duodenal ulcer disease N Engl J Med 335 4 1996 242 249
77. D. Kumar, A. Dhar, and S. Dattagupta Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer Indian J Gastroenterol 21 1 2002 7 10
78. J.E. Crabtree, J.I. Wyatt, and G.M. Sobala Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer Gut 34 10 1993 1339 1343
79. M. Asaka, T. Kimura, and M. Kato Possible role of Helicobacter pylori infection in early gastric cancer development Cancer 73 11 1994 2691 2694
80. P. Lauren The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma Acta Pathol Microbiol Scand [A] 64 1965 31 49
81. P. Sipponen, H. Hyvarinen, and K. Seppala Review article: pathogenesis of the transformation from gastritis to malignancy Aliment Pharmacol Ther 12 Suppl 1 1998 61 71
82. M. Kato, M. Asaka, and Y. Shimizu Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer Aliment Pharmacol Ther 20 Suppl 1 2004 85 89
83. K. Kimura Gastritis and gastric cancer: Asia Gastroenterol Clin North Am 29 3 2000 609 621
84. J. Valle, M. Kekki, and P. Sipponen Long-term course and consequences of Helicobacter pylori gastritis: results of a 32-year follow-up study Scand J Gastroenterol 31 6 1996 546 550
85. M. Cassaro, M. Rugge, and O. Gutierrez Topographic patterns of intestinal metaplasia and gastric cancer Am J Gastroenterol 95 6 2000 1431 1438
86. M.I. Filipe, N. Munoz, and I. Matko Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia Int J Cancer 57 3 1994 324 329
87. H.M. El-Zimaity, J. Ramchatesingh, and M.A. Saeed Gastric intestinal metaplasia: subtypes and natural history J Clin Pathol 54 9 2001 679 683
88. N. Ectors, and M.F. Dixon The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer Histopathology 10 12 1986 1271 1277
89. N. Uemura, and S. Okamoto Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer in Japan Gastroenterol Clin North Am 29 4 2000 819 827
90. J.H. Lee, S.C. Abraham, and H.S. Kim Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma Am J Pathol 161 2 2002 611 618
91. L. Ottini, D. Palli, and M. Falchetti Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany Cancer Res 57 20 1997 4523 4529
92. X.L. Ling, D.C. Fang, and R.Q. Wang Mitochondrial microsatellite instability in gastric cancer and its precancerous lesions World J Gastroenterol 10 6 2004 800 803
93. A. Boussioutas, H. Li, and J. Liu Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer Cancer Res 63 10 2003 2569 2577
94. M. Kimura, S. Goto, and A. Wada Vacuolating cytotoxin purified from Helicobacter pylori causes mitochondrial damage in human gastric cells Microb Pathog 26 1 1999 45 52
95. A. Galmiche, J. Rassow, and A. Doye The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release EMBO J 19 23 2000 6361 6370
96. J.R. Warren Gastric pathology associated with Helicobacter pylori Gastroenterol Clin North Am 29 3 2000 705 751
97. W.S. Park, R.R. Oh, and J.Y. Park Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer Cancer Res 59 17 1999 4257 4260
98. G. Berx, K.F. Becker, and H. Hofler Mutations of the human E-cadherin (CDH1) gene Hum Mutat 12 4 1998 226 237
99. P. Guilford, J. Hopkins, and J. Harraway E-cadherin germline mutations in familial gastric cancer Nature 392 6674 1998 402 405
100. W.M. Grady, J. Willis, and P.J. Guilford Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer Nat Genet 26 1 2000 16 17
101. B. Mayer, J.P. Johnson, and F. Leitl E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration Cancer Res 53 7 1993 1690 1695
102. K. Vleminckx, L. Vakaet Jr., and M. Mareel Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role Cell 66 1 1991 107 119
103. V.S. Conlin, S.B. Curtis, and Y. Zhao Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells Infect Immun 72 9 2004 5181 5192
104. J.W. Lim, H. Kim, and K.H. Kim Cell adhesion-related gene expression by Helicobacter pylori in gastric epithelial AGS cells Int J Biochem Cell Biol 35 8 2003 1284 1296
105. M. Obonyo, D.G. Guiney, and J. Harwood Role of gamma interferon in Helicobacter pylori induction of inflammatory mediators during murine infection Infect Immun 70 6 2002 3295 3299
106. N. Sawai, M. Kita, and T. Kodama Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model Infect Immun 67 1 1999 279 285
107. H.V. Malling Incorporation of mammalian metabolism into mutagenicity testing Mutat Res 566 3 2004 183 189
108. J.J. Kim, H. Tao, and E. Carloni Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells Gastroenterology 123 2 2002 542 553
109. D.A. Lynch, N.P. Mapstone, and A.M. Clarke Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy Gut 36 3 1995 346 350
110. R.J. Cahill, C. Kilgallen, and S. Beattie Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma Gut 38 2 1996 177 181
111. F. Petersson, K. Borch, and L.E. Franzen Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H pylori infection Dig Dis Sci 47 7 2002 1558 1566
112. S.P. Hussain, K. Raja, and P.A. Amstad Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: Oxyradical overload diseases Proc Natl Acad Sci USA 97 23 2000 12770 12775
113. G.J. Jenkins The restriction site mutation (RSM) method: clinical applications Mutagenesis 19 1 2004 3 11
114. T. Oda, K. Murakami, and A. Nishizono Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene Helicobacter 7 3 2002 143 151
115. K. Murakami, T. Fujioka, and M. Kodama Analysis of p53 mutations and Helicobacter pylori infection in human and animal models J Gastroenterol 37 Suppl 13 2002 1 5
116. H. Higashi, R. Tsutsumi, and S. Muto SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein Science 295 5555 2002 683 686
117. H. Higashi, R. Tsutsumi, and A. Fujita Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites Proc Natl Acad Sci U S A 99 22 2002 14428 14433
118. R.H. Argent, M. Kidd, and R.J. Owen Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori Gastroenterology 127 2 2004 514 523
119. H. Mimuro, T. Suzuki, and J. Tanaka Grb2 is a key mediator of Helicobacter pylori CagA protein activities Mol Cell 10 4 2002 745 755
120. H. Higashi, A. Nakaya, and R. Tsutsumi Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation J Biol Chem 279 17 2004 17205 17216
121. K. Guillemin, N.R. Salama, and L.S. Tompkins Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection Proc Natl Acad Sci U S A 99 23 2002 15136 15141
122. P. Correa, G. Malcom, and B. Schmidt Review article: antioxidant micronutrients and gastric cancer Aliment Pharmacol Ther 12 Suppl 1 1998 73 82
123. H. Suzuki, K. Seto, and M. Mori Monochloramine induced DNA fragmentation in gastric cell line MKN45 Am J Physiol 275 4 Pt 1 1998 G712 G716
124. L.J. Marnett Chemistry and biology of DNA damage by malondialdehyde IARC Sci Publ 150 1999 17 27
125. L.A. VanderVeen, M.F. Hashim, and Y. Shyr Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde Proc Natl Acad Sci U S A 100 24 2003 14247 14252
126. S. Tamir, and S.R. Tannenbaum The role of nitric oxide (NO.) in the carcinogenic process Biochim Biophys Acta 1288 2 1996 F31 F36
127. A.P. Gobert, D.J. McGee, and M. Akhtar Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival Proc Natl Acad Sci U S A 98 24 2001 13844 13849
128. K. Hinuma, J. Matsuda, and N. Tanida N-nitrosamines in the stomach with special reference to in vitro formation, and kinetics after intragastric or intravenous administration in rats Gastroenterol Jpn 25 4 1990 417 424
129. G.M. Sobala, C.J. Schorah, and S. Shires Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations Gut 34 8 1993 1038 1041
130. N. Munoz, and S. Franceschi Epidemiology of gastric cancer and perspectives for prevention Salud Publica Mex 39 4 1997 318 330
131. L. Cai, Z.L. Zheng, and Z.F. Zhang Risk factors for the gastric cardia cancer: a case-control study in Fujian Province World J Gastroenterol 9 2 2003 214 218
132. T. Ohkusa, K. Fujiki, and I. Takashimizu Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated Ann Intern Med 134 5 2001 380 386
133. M. Rugge, P. Correa, and M.F. Dixon Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading Aliment Pharmacol Ther 16 7 2002 1249 1259
134. J. Parsonnet, R.A. Harris, and H.M. Hack Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials Lancet 348 9021 1996 150 154
135. P.W. Groeneveld, T.A. Lieu, and A.M. Fendrick Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia Am J Gastroenterol 96 2 2001 338 347
136. H. Brenner, V. Arndt, and C. Stegmaier Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 159 3 2004 252 258
137. D. Rothenbacher, and H. Brenner Helicobacter pylori and gastric cancer Gastroenterology 126 7 2004 1927
138. A.C. Wotherspoon, C. Doglioni, and T.C. Diss Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori Lancet 342 8871 1993 575 577
139. A. Morgner, C. Thiede, and E. Bayerdorffer Long-term follow-up of gastric MALT lymphoma after H pylori eradication Curr Gastroenterol Rep 3 6 2001 516 522
140. C. Montalban, J.M. Castrillo, and V. Abraira Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma: clinicopathological study and evaluation of the prognostic factors in 143 patients Ann Oncol 6 4 1995 355 362
141. S. Alkan, D.S. Karcher, and M.A. Newman Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori Lancet 348 9022 1996 268 269
142. C. Montalban, A. Santon, and D. Boixeda Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication: long-term results after sequential histologic and molecular follow-up Haematologica 86 6 2001 609 617
143. E. Bayerdorffer, A. Neubauer, and B. Rudolph Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group Lancet 345 8965 1995 1591 1594
144. J.E. Crabtree, and J. Spencer Immunologic aspects of Helicobacter pylori infection and malignant transformation of B cells Semin Gastrointest Dis 7 1 1996 30 40
145. Y. Matsushima, Y. Kinoshita, and H. Fukui Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication? J Gastroenterol 37 6 2002 428 433
146. C. Thiede, T. Wundisch, and B. Neubauer Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial Recent Results Cancer Res 156 2000 125 133
147. A. Morgner, E. Bayerdorffer, and A. Neubauer Malignant tumors of the stomach: gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori Gastroenterol Clin North Am 29 3 2000 593 607